TransMedics(TMDX)
Search documents
TransMedics(TMDX) - 2020 Q1 - Quarterly Report
2020-05-06 21:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of registrant as specified in its charter) Massachusetts 83-2181531 ( ...
TransMedics(TMDX) - 2019 Q4 - Annual Report
2020-03-17 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of Registrant as specified in its Charter) Massachusetts 83-2181531 (State or other jurisd ...
TransMedics Group (TMDX) Investor Presentation - Slideshow
2020-03-03 18:50
Organ Care System (OCS") Redefining What's Possible in Organ Transplantation | --- | --- | |-------|-------| | | | | | | The OCS is the only technology platform addressing lung, heart and liver transplant therapy Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our results of operations, commercial opportunity and the rate of adoption ...
TransMedics(TMDX) - 2019 Q4 - Earnings Call Transcript
2020-03-03 01:27
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2019 Earnings Conference Call March 2, 2020 4:30 PM ET Company Participants Brian Johnston - Managing Director, Gilmartin Group Waleed Hassanein - Founder, President and Chief Executive Officer Stephen Gordon - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan David Lewis - Morgan Stanley Jason Mills - Canaccord Genuity Group Inc. Operator Good day, ladies and gentlemen, and welcome to the TransMedics Fourth Quarter and Full-Year 2019 Earning ...
TransMedics (TMDX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
2020-01-16 20:11
Organ Care System (OCS") Redefining What's Possible in Organ Transplantation | --- | --- | |--------------------------------------------------------------------------|-------| | | | | that is transforming organ transplantation to a more dynamic environment | | The OCS is the only technology platform addressing lung, heart and liver transplant therapy Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance ...
TransMedics(TMDX) - 2019 Q2 - Earnings Call Transcript
2019-08-10 17:49
Transmedics Group, Inc. (NASDAQ:TMDX) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Gregory Chodaczek - Gilmartin Group Waleed Hassanein - Founder, CEO, President & Director Stephen Gordon - CFO. Treasurer & Secretary Conference Call Participants David Lewis - Morgan Stanley Christian Moore - JPMorgan Chase & Co. Joshua Jennings - Cowen and Company Jason Mills - Canaccord Genuity Corp. Operator Good afternoon, ladies and gentlemen, and welcome to the TransMedics Second Quar ...
TransMedics (TMDX) Investor Presentation - Slideshow
2019-08-09 18:30
Organ Care System (OCS") Redefining What's Possible in Organ Transplantation | --- | --- | |-------|-------| | | | | | | The OCS is the only technology platform addressing lung, heart and liver transplant therapy Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our results of operations, commercial opportunity and the rate of adoption ...
TransMedics(TMDX) - 2019 Q1 - Earnings Call Transcript
2019-06-12 00:46
TransMedics, Inc. (NASDAQ:TMDX) Q1 2019 Results Conference Call June 11, 2019 4:30 PM ET Company Participants Greg Chodaczek - IR Waleed Hassanein - President and Chief Executive Officer Stephen Gordon - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Robbie Marcus - JP Morgan Josh Jennings - Cowen Operator Good day, ladies and gentlemen, and welcome to the TransMedics First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Lat ...